Science AI Journal
Medicine · Research topic

Open research questions in Uterine Myomas and Treatments

126 unresolved questions extracted from the limitations and future-work sections of 517 Uterine Myomas and Treatments papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The study used a mouse model, which may not be directly applicable to humans. The study had a limited sample size of 80 mice. The study only explored the effects of chicoric acid on the p38 MAPK/NF-κB pathway. The study did not investigate the long-term effects of chicoric acid on the inflammatory response.

    Chicoric acid regulates IL-1β to improve the inflammatory response in mice undergoing myomectomy under propofol anesthesia · 2026 · DOI

  • Investigate the effects of chicoric acid on other inflammatory pathways. Explore the use of chicoric acid in combination with other anti-inflammatory agents. Conduct studies in larger animal models or humans to confirm the findings. Investigate the optimal dosage and duration of chicoric acid treatment.

    Chicoric acid regulates IL-1β to improve the inflammatory response in mice undergoing myomectomy under propofol anesthesia · 2026 · DOI

  • However, the long-term impact of the procedure on ovarian function remains unknown.

    Effect of opportunistic salpingectomy at hysterectomy on anti‐Müllerian hormone: A substudy of a randomized trial · 2026 · DOI

  • The risks of perinatal complications after myomectomy should be assessed and addressed at the individual level based on the specific myomectomy method, but further research on the optimal TIMP is warranted.

    Perinatal complications and time to subsequent pregnancy after open, laparoscopic, and hysteroscopic myomectomy: a retrospective cohort study · 2026 · DOI

  • INTRODUCTION: The effects of benign hysterectomy on sexual function and pelvic floor remain uncertain.

    Sexual function and pelvic floor function five years after hysterectomy · 2025 · DOI

  • However, studies evaluating the safety and cost-effectiveness of hysteroscopic myomectomy under procedural sedation and analgesia are lacking.

    Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy: A cost‐effectiveness analysis alongside a randomized controlled trial · 2025 · DOI

  • Data on feasibility, reproducibility, and reliability of MV-flow imaging in fibroids is lacking.

    Microvascular flow imaging of fibroids: A prospective pilot study · 2024 · DOI

  • The role of lymphadenectomy remains uncertain, emphasizing the importance of individualized treatment approaches.

    Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study · 2024 · DOI

  • Future research should explore molecular profiling to further refine prognostication and therapeutic strategies for this challenging malignancy.

    Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study · 2024 · DOI

  • Prior studies of the importance of family history on fibroid development are limited by reliance on hospital-based participant selection, poorly defined measures of family history, and nonsystematic fibroid assessment.

    Family History and Uterine Fibroid Development in Black and African American Women · 2024 · DOI

  • Importance: Uterine fibroids are an understudied condition, with earlier onset in Black than White women.

    Family History and Uterine Fibroid Development in Black and African American Women · 2024 · DOI

  • The Senhance Surgical System has gained prominence for total hysterectomies from single-site experiences, but multi-site reporting are still lacking in present literature.

    Exploring robotic total hysterectomies: a multi-site experience with the Senhance Surgical System · 2024 · DOI

  • The aggressive clinical course of uterine sarcoma makes it challenging to treat. The high risk of local or distant recurrences is a significant challenge in the management of the disease. The lack of a unified algorithm for the selection of adjuvant therapy is a challenge in the treatment of uterine sarcoma.

    RESULTS OF TREATMENT OF PATIENTS WITH STAGE II UTERINE SARCOMA · 2026 · DOI

  • There is a need for further research on the clinical characteristics and treatment outcomes of patients with uterine sarcoma. The study aims to address this gap by analyzing the anamnestic data of patients with LMS II stage.

    RESULTS OF TREATMENT OF PATIENTS WITH STAGE II UTERINE SARCOMA · 2026 · DOI

  • The diagnosis and treatment of ULMS are challenging due to its high recurrence rate and poor prognosis. The current diagnostic methods may not be accurate or reliable. The development of novel diagnostic biomarkers is needed to improve patient outcomes.

    Identification of the key immune and inflammatory related gene CALCRL as diagnostic biomarker in differentiating uterine leiomyosarcoma from leiomyoma · 2026 · DOI

  • The current diagnosis and treatment of ULMS are limited. There is a need for novel diagnostic biomarkers to differentiate ULMS from ULM.

    Identification of the key immune and inflammatory related gene CALCRL as diagnostic biomarker in differentiating uterine leiomyosarcoma from leiomyoma · 2026 · DOI

  • IVL can be asymptomatic until it reaches an advanced stage. The tumor can extend into the IVC via the pelvic vessels and further into the right atrium. Complete surgical resection is critical for successful treatment.

    Case Report: A Case of Intravenous Leiomyomatosis Involving the Inferior Vena Cava and Right Atrium · 2026 · DOI

  • IVL is a rare and understudied condition. There is a need for additional nonsurgical treatment options.

    Case Report: A Case of Intravenous Leiomyomatosis Involving the Inferior Vena Cava and Right Atrium · 2026 · DOI

  • The study identifies a gap in our understanding of the molecular mechanisms underlying fibroid development and progression. The study highlights the need for further research into the gene expression programs that regulate the proliferation and differentiation of myometrial and MED12-mutant leiomyoma stem cells.

    Stem cell activation in organ culture reveals novel transcriptional programs underlying metabolic, fibrotic, vascular, and immune dysregulation in uterine leiomyomas · 2026 · DOI

  • The organ culture platform revealed stem cell activation in normal myometrium with potential for investigating proliferation, differentiation, and ECM remodeling mechanisms fundamental to tissue function. This approach should be extended to other fibrotic conditions (liver, pulmonary, and cardiac fibrosis) using available slice culture methods to identify whether resident stem cell activation is a common mechanism promoting fibrotic remodeling across tissues.

    Stem cell activation in organ culture reveals novel transcriptional programs underlying metabolic, fibrotic, vascular, and immune dysregulation in uterine leiomyomas · 2026 · DOI

  • Abnormal uterine bleeding (AUB) is a common gynecologic complaint with significant quality of life and healthcare burden implications. The management of AUB is challenging due to the variety of treatment options and the need for individualized care. The study's findings may inform clinical decision-making and guideline development for the management of AUB.

    Impact of levonorgestrel-releasing intrauterine device on amenorrhea rates after endometrial resection or ablation in women with abnormal uterine bleeding · 2026 · DOI

  • There is a need to evaluate the effectiveness of adjunctive LNG-IUD placement in improving amenorrhea outcomes and reducing hysterectomy rates in women with AUB. The study aims to address this gap by investigating the association between LNG-IUD use and the risks of amenorrhea and hysterectomy.

    Impact of levonorgestrel-releasing intrauterine device on amenorrhea rates after endometrial resection or ablation in women with abnormal uterine bleeding · 2026 · DOI

  • The lack of standardized management guidelines for STUMP. The diagnostic uncertainty of STUMP significantly impacts surgical planning.

    Balancing Fertility and Oncologic Uncertainty: Robotic Myomectomy With Bilateral Uterine Artery Ligation for Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) · 2026 · DOI

  • The paper identifies a gap in the literature regarding the management of hemorrhagic myomas delivered through the cervix. The paper highlights the need for more research on this condition.

    Prise en charge d'un myome hémorragique accouché par le col sur grossesse de 29 semaines d’aménorrhée : à propos d'un cas · 2026 · DOI

  • The study had a limited sample size of 638 women. The study only analyzed a subset of umbilical cord blood samples for hormone analysis. The difference in time to conceive between the two groups may represent a type I error.

    Challenging the paradigm that neonatal uterine bleeding represents the first menstrual episode · 2026 · DOI

Most-cited papers in Uterine Myomas and Treatments

Most recent work

Find a gap in your own Uterine Myomas and Treatments sub-topic

This page shows what the Uterine Myomas and Treatments literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,044 open questions
Substance Abuse Treatment and Outcomes
1,964 open questions
Smoking Behavior and Cessation
990 open questions
Dementia and Cognitive Impairment Research
974 open questions
Innovations in Medical Education
960 open questions
Physical Activity and Health
923 open questions
Attention Deficit Hyperactivity Disorder
839 open questions
Schizophrenia research and treatment
709 open questions
126 open questions have been extracted from the limitations and future-work passages of 517 Uterine Myomas and Treatments papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.